Evidence map›Paper›PMID 42115727›Full record

ArticleScientific reports2026

Genetic diversity of the IC/3D7 allelic family of the merozoite surface protein 2 (MSP2) of Plasmodium falciparum and multiplicity of infection in four health facilities in the Mbouda Health District, Cameroon.

Yamssi Cedric, Noumedem Anangmo Christelle Nadia, Toumko Towa Merveille, Tchuenkam Kom Pacome, Kenfack Tsague Mathieu, Gamago Nkadeu Guy-Armand, Djobo Abel, Guela Djoukou Mba Edna, Wansi Noumbissi Inès Sandra, Kana Tsague Yval and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yamssi CedricDepartment of Biomedical Sciences, University of Bamenda, Bambili, Cameroon. cyamssi@yahoo.com.
Noumedem Anangmo Christelle NadiaLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon. noums11@yahoo.fr.
Toumko Towa MerveilleLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Tchuenkam Kom PacomeLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Kenfack Tsague MathieuLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Gamago Nkadeu Guy-ArmandLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Djobo AbelDepartment of Biomedical Sciences, University of Bamenda, Bambili, Cameroon.
Guela Djoukou Mba EdnaLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Wansi Noumbissi Inès SandraLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Kana Tsague YvalLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon.
Haibo HuLaboratory of Tropical and Emerging Infectious Diseases, Dschang, Cameroon. hhb2017@gmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic variability of Plasmodium falciparum serves as an important marker of the parasite's ability to adapt and develop resistance to antimalarial treatments. This study sought to evaluate the diversity of the P. falciparum merozoite surface protein 2 (msp2) gene among patients receiving care in four health centers in the Mbouda Health District, Cameroon. Blood samples were obtained from 481 individuals who came for diagnostic testing with symptoms suggestive of malaria. Rapid diagnostic tests and thick blood smears were performed to confirm P. falciparum infection and determine parasite density, respectively. Positive samples were spotted onto Whatman filter paper for molecular testing. DNA was extracted using the Chelex-100 technique, and msp2 fragments were amplified via nested PCR. Amplicons were separated on 1.3% agarose gels and visualized under UV light. Phylogenetic analysis was performed in R, and statistical analyses were conducted using SPSS version 23. Out of the 481 samples analyzed, 137 (28.48%) tested positive for P. falciparum, with a mean parasite density of 2196.77 ± 1344.36 parasites/µL. Female participants showed a weakly significant association with malaria infection, while children aged 0-5 years, despite having an odds ratio above 1, did not show a statistically significant association. The msp2 gene was successfully amplified in 64% of positive samples, revealing 15 distinct alleles. The overall genetic diversity was 14.15%, with a mean multiplicity of infection (MOI) of 1.20. The proportions of mono-, double-, and triple-genotype infections were 81.68%, 18.18%, and 1.33%, respectively. Phylogenetic analysis identified 13 distinct clades, indicating genetic relatedness among circulating P. falciparum strains. A considerable level of genetic diversity and multiple infections was detected among P. falciparum isolates in the Mbouda Health District, suggesting high transmission intensity. Further studies incorporating additional molecular markers such as msp1 and GLURP are recommended to provide a more comprehensive picture of P. falciparum genetic variation in the region.

Indexed as

Antigens, ProtozoanGenetic VariationMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsAdolescentAdultAllelesCameroonChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedAntigens, Protozoanmerozoite surface protein 2, PlasmodiumProtozoan ProteinsAlleleGenetic diversityMalariamsp2Multiplicity of infection

Identifiers

PMID42115727
PMCPMC13351056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.